204 related articles for article (PubMed ID: 12796362)
61. The murine Pou6f2 gene is temporally and spatially regulated during kidney embryogenesis and its human homolog is overexpressed in a subset of Wilms tumors.
Di Renzo F; Doneda L; Menegola E; Sardella M; De Vecchi G; Collini P; Spreafico F; Fossati-Bellani F; Giavini E; Radice P; Perotti D
J Pediatr Hematol Oncol; 2006 Dec; 28(12):791-7. PubMed ID: 17164647
[TBL] [Abstract][Full Text] [Related]
62. Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications.
Sugimura J; Yang XJ; Tretiakova MS; Takahashi M; Kort EJ; Fulton B; Fujioka T; Vogelzang NJ; Teh BT
Urology; 2004 Aug; 64(2):362-8; discussion 368. PubMed ID: 15302496
[TBL] [Abstract][Full Text] [Related]
63. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
64. Extracellular matrix and epithelial differentiation of Wilms' tumor.
Sariola H; Ekblom P; Rapola J; Vaheri A; Timpl R
Am J Pathol; 1985 Jan; 118(1):96-107. PubMed ID: 2981473
[TBL] [Abstract][Full Text] [Related]
65. Diagnostic pitfalls of differentiating desmoplastic small round cell tumor (DSRCT) from Wilms tumor (WT): overlapping morphologic and immunohistochemical features.
Arnold MA; Schoenfield L; Limketkai BN; Arnold CA
Am J Surg Pathol; 2014 Sep; 38(9):1220-6. PubMed ID: 24832162
[TBL] [Abstract][Full Text] [Related]
66. The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells.
Wagner N; Wagner KD; Schley G; Coupland SE; Heimann H; Grantyn R; Scholz H
Cell Growth Differ; 2002 Jul; 13(7):297-305. PubMed ID: 12133898
[TBL] [Abstract][Full Text] [Related]
67. A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity.
Murphy AJ; Bishop K; Pereira C; Chilton-MacNeill S; Ho M; Zielenska M; Thorner PS
Hum Pathol; 2008 Dec; 39(12):1763-70. PubMed ID: 18703217
[TBL] [Abstract][Full Text] [Related]
68. WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2.
Discenza MT; He S; Lee TH; Chu LL; Bolon B; Goodyer P; Eccles M; Pelletier J
Oncogene; 2003 Nov; 22(50):8145-55. PubMed ID: 14603255
[TBL] [Abstract][Full Text] [Related]
69. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes).
Auber F; Lortat-Jacob S; Sarnacki S; Jaubert F; Salomon R; Thibaud E; Jeanpierre C; Nihoul-Fékété C
J Pediatr Surg; 2003 Jan; 38(1):124-9; discussion 124-9. PubMed ID: 12592634
[TBL] [Abstract][Full Text] [Related]
70. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
71. The Wilms' tumor gene WT1 is a common marker of progenitor cells in fetal liver.
Kanato K; Hosen N; Yanagihara M; Nakagata N; Shirakata T; Nakazawa T; Nishida S; Tsuboi A; Kawakami M; Masuda T; Oka Y; Oji Y; Ijpenberg A; Hastie ND; Sugiyama H
Biochem Biophys Res Commun; 2005 Jan; 326(4):836-43. PubMed ID: 15607745
[TBL] [Abstract][Full Text] [Related]
72. [Expression of WT1mRNA: relation to histology in Wilm's tumor].
Hu CG; Jin BX; Shen ZZ
Zhonghua Wai Ke Za Zhi; 1994 Dec; 32(12):712-4. PubMed ID: 7774415
[TBL] [Abstract][Full Text] [Related]
73. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
74. Kidneys and sex, the Wilms' tumor connection.
Kreidberg J
Pediatr Res; 2002 Feb; 51(2):128. PubMed ID: 11809904
[No Abstract] [Full Text] [Related]
75. Examination of expression of WT1 gene product and CD44 adhesive molecule in nephroblastoma histologic types.
Taran K; Kobos J; Sporny S
Pol J Pathol; 2008; 59(3):177-82. PubMed ID: 19097357
[TBL] [Abstract][Full Text] [Related]
76. Cluster analysis of immunohistochemical markers in leiomyosarcoma delineates specific anatomic and gender subgroups.
Carvalho JC; Thomas DG; Lucas DR
Cancer; 2009 Sep; 115(18):4186-95. PubMed ID: 19626649
[TBL] [Abstract][Full Text] [Related]
77. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia.
Li W; Kessler P; Williams BR
Oncogene; 2005 Jan; 24(3):457-68. PubMed ID: 15531917
[TBL] [Abstract][Full Text] [Related]
78. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.
Galimberti S; Guerrini F; Carulli G; Fazzi R; Palumbo GA; Morabito F; Petrini M
Eur J Haematol; 2004 Jan; 72(1):45-51. PubMed ID: 14962262
[TBL] [Abstract][Full Text] [Related]
79. Constitutional WT1 mutations in Wilms' tumor patients.
Diller L; Ghahremani M; Morgan J; Grundy P; Reeves C; Breslow N; Green D; Neuberg D; Pelletier J; Li FP
J Clin Oncol; 1998 Nov; 16(11):3634-40. PubMed ID: 9817285
[TBL] [Abstract][Full Text] [Related]
80. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
